EKF Diagnostics Holdings plc (LON:EKF – Get Free Report)’s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 27.67 ($0.34) and traded as low as GBX 25.80 ($0.32). EKF Diagnostics shares last traded at GBX 26.35 ($0.32), with a volume of 248,776 shares changing hands.
EKF Diagnostics Trading Down 2.0 %
The business has a 50-day moving average of GBX 25.98 and a 200 day moving average of GBX 27.67. The stock has a market cap of £117.11 million, a PE ratio of 2,581.10 and a beta of 0.57. The company has a debt-to-equity ratio of 1.78, a quick ratio of 1.77 and a current ratio of 4.59.
EKF Diagnostics Company Profile
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.
See Also
- Five stocks we like better than EKF Diagnostics
- What is the FTSE 100 index?
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- How Do Stock Buybacks Affect Shareholders?
- How to Invest in Biotech Stocks
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
